Hassett Calls Record Credit Card Spending a Win as Delinquencies Rise and Farm Bankruptcies Surge 46
From Singapore to Brussels World Leaders Eye Potential TrumpXi Summit
Micron Advances Memory Technology Dicks Sporting Reports Results Paxton Political Development
Qualcomms Recent Stock Rally Signals Growing Investor Confidence in AI Device Expansion
Meta Tests AI Subscription Plans Starting at 799 Monthly
SpaceX Files for Public Offering Potentially Making Elon Musk a Trillionaire
CUE Q3 2025 Earnings Narrower Loss Drives Positive Market Response
Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure
FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged
ADAMH Q1 2026 Earnings Senior Notes Trust Surpasses Estimates with Strong Earnings Surprise
MGM Q1 2026 Earnings EPS Miss Triggers Cautious Optimism as Shares Advance
YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures
Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector
LuxExperience LUXE Slides 14 as Selling Pressure Builds Near Support
Alamo Group Inc ALG Climbs 163 as Shares Test Key Resistance Near 160
Nuveen Arizona Quality Municipal Income Fund NAZ Holds Steady Near Support Amid Modest Decline
Sensient Technologies SXT Shows Resilience with 130 Gain Eyes Resistance at 12430
Nvidia Earnings Call in Focus Market Watches for Commentary on China Chip Restrictions and Geopolitical Tensions
Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers
Singapore Lifts 2026 Export Growth Forecast on AIDriven Demand
Prediction Markets Face Mounting Legal Challenges as 16 States Take Action Against Platforms
Technical Indicators Point to Bullish Bias in Intermediate Term
NY Fed Study Reveals Surge in Food Insecurity Among Vulnerable Americans
Iran Intensifies Claims Over Strait of Hormuz with New Map of Armed Forces Oversight
Cyngn Inc CYN Q1 2026 Earnings Narrowerthanexpected loss props up shares
Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain